The Bladder Flap at Cesarean Section: A Randomized Controlled Trial
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Jun 9, 2009
Trial Information
Current as of November 05, 2025
Completed
Keywords
ClinConnect Summary
BACKGROUND
Cesarean section is the most common major surgical procedure in women world wide. In the United States almost 25% of deliveries are by cesarean section and the rate continues to rise \[1\]. In performing this procedure, it is imperative that evidence based techniques are utilized to optimize outcomes and minimize complications. Recently, the case has been made for simplifying the procedure by eliminating unnecessary and potentially harmful steps \[2\].
Rationale for the Bladder Flap Challenged: While the creation of the bladder flap has long been an integral part of the standar...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients undergoing non-emergent primary and repeat cesarean sections at or greater than 32 weeks gestation at Barnes Jewish Hospital during the study period.
- Exclusion Criteria:
- • Emergent cesarean sections, planned vertical uterine incision, previous abdominal surgeries (besides prior cesarean sections), sedation and inability to obtain consent.
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
St Louis, Missouri, United States
Patients applied
Trial Officials
George A. Macones, MD, MSCE
Principal Investigator
Washington University School of Medicine
Methodius G. Tuuli, M.D., M.P.H.
Principal Investigator
Washington University School of Medicine
Anthony Odibo, MD, MSCE
Principal Investigator
Washington University School of Medicine
Patricia Fogertey, BSN, MSN
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials